INMUNE BIO INC. Interest Expense on Prepetition Liabilities Recognized in Statement of Operations
INMUNE BIO INC. (INMB) reported Interest Expense on Prepetition Liabilities Recognized in Statement of Operations of $985.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Expense Statement
us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations · last filed 2022-03-03
- INMUNE BIO INC. interest expense on prepetition liabilities recognized in statement of operations for the quarter ending 2021-12-31 was $485.00K.
- INMUNE BIO INC. interest expense on prepetition liabilities recognized in statement of operations for the quarter ending 2021-09-30 was $400.00K.
- INMUNE BIO INC. interest expense on prepetition liabilities recognized in statement of operations for the quarter ending 2021-06-30 was $100.00K.
- INMUNE BIO INC. interest expense on prepetition liabilities recognized in statement of operations for the quarter ending 2021-03-31 was $0.00.
- INMUNE BIO INC. interest expense on prepetition liabilities recognized in statement of operations for fiscal 2021 was $985.00K.
| Period end | Interest Expense on Prepetition Liabilities Recognized in Statement of Operations 3 month | Interest Expense on Prepetition Liabilities Recognized in Statement of Operations 6 month | Interest Expense on Prepetition Liabilities Recognized in Statement of Operations 9 month | Interest Expense on Prepetition Liabilities Recognized in Statement of Operations 12 month |
|---|---|---|---|---|
| 2021-12-31 | $485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $885.00K derived: sum of 2 quarters · filed 2022-03-03 | $985.00K derived: sum of 3 quarters · filed 2022-03-03 | $985.00K 10-K · filed 2022-03-03 |
| 2021-09-30 | $400.00K 10-Q · filed 2021-11-03 | $500.00K derived: sum of 2 quarters · filed 2021-11-03 | $500.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $100.00K 10-Q · filed 2021-08-04 | $100.00K 10-Q · filed 2021-08-04 | ||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |